Supernus Pharmaceuticals

SUPNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.487 B

$42.78 +1.86%

Close of 21 Sept 2026

Revenue

$719.0M

#1723 by revenue

Earnings

-$38.6M

Loss-making

Shares outstanding

58,127,013

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#87PharvarisPHVS$2.51B
#88Mineralys TherapeuticsMLYS$2.50B
#89Supernus PharmaceuticalsSUPN$2.49B
#90Vera TherapeuticsVERA$2.47B
#91Harmony BiosciencesHRMY$2.45B

What if Supernus Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$520,825.90

Per share 12,175× higher

Bitcoin $1.72T

$29,587.00

Per share 692× higher

Nvidia $5.48T

$94,273.86

Per share 2,204× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Supernus Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.